A summary of the translation initiation factors as well as the components of the PI3K/AKT/mTOR pathway used as therapeutic targets in PCa is depicted in Figure 1 (Kinkade et al., 2008; Edlind and Hsieh, 2014). This evidence concerns the gene PIK3CA and posterior cortical atrophy.